Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,740Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-99.3EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)21.1Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.410-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %2.2PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M12,100,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IYH

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

IYH is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


IYH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Snow, Jeffery AlexanderSenior Officer 2016-12-08Buy90,000$5.122709.38view
DINWOODIE, TYLER WAYNE PAULSenior Officer 2016-12-08Buy10,000$0.13110546.15view
Grant, Cheryl AnnDirector, Senior Officer 2016-12-08Buy19,000$0.06239633.33view
Fowler, Christopher HectorSenior Officer 2016-12-08Buy429$32.1348.1view
Fowler, Christopher HectorSenior Officer 2016-12-08Buy14$32.11347.96view
Big Sky Uranium Inc.Director, Senior Officer 2016-12-08Buy2,500$1.1212742.86view
Roy, Claude10% Security Holder, Director, Senior Officer 2016-12-08Buy400$18.95659.05view
Roy, Claude10% Security Holder, Director, Senior Officer 2016-12-08Buy600$18.97658.25view
PAMPLIN, Ann-Marie MichelleDeemed Insider - 6 Months before becoming Insider 2016-12-08Buy15,000$0.13110546.15view
Skoda, Edward FranklinDirector 2016-12-08Buy25,000$0.2362439.13view

Quarterly/Annual Reports about IYH:

    News about IYH:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Listing the Reasons behind Pfizer’s Discounted Price-to-Earnings Dec 09 2016
    Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares Dec 07 2016
    The Fuel for Today’s Reflationary Fire: What You Need to Know Dec 02 2016
    Which US Sectors Look Appealing in the Reflationary Environment? Dec 02 2016
    These Pfizer Products Saw Falling Revenues in 3Q16 Nov 30 2016
    Pfizer’s Innovative and Essential Health Businesses Nov 30 2016
    Is Gilead Sciences Stock Oversold? Nov 28 2016
    These Will Be the Challenges to BMY’s Opdivo in the Lung Cancer Space Nov 22 2016
    Inside Bristol-Myers Squibb’s Upward Revision of Guidance Nov 22 2016
    Inside Eli Lilly’s Revenue Trends Nov 22 2016
    Opdivo’s Approval for Head and Neck Cancer: Another Feather in Bristol’s Cap? Nov 18 2016
    What’s Bristol-Myers Squibb Stock Been Up To? Nov 18 2016
    Ahead of Obamacare Open Enrollment, Are Health Care ETFs a Risk? Oct 25 2016
    J&J Beats on Q3 Earnings: Should You Buy Healthcare ETFs? Oct 18 2016
    3 ETFs to Buy if You Think Johnson & Johnson Will Beat Earnings Oct 17 2016
    Four Key Deals: Analyzing Pfizer’s Impending Growth Oct 14 2016
    Does Pfizer Deserve a Better Valuation? Oct 13 2016
    How Large of a Role Does Opdivo Play in Bristol-Myers Squibb’s Success? Oct 12 2016
    Bristol-Myers Squibb’s Strategies to Dominate Immuno-Oncology Market Oct 11 2016
    Understanding the Recent Fall in Bristol-Myers Squibb’s Valuation Oct 07 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)